首页> 外文期刊>Acta medica (Hradec Kralove) / >Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition
【24h】

Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition

机译:G6PD缺乏药物诱导的溶血:常见临床状况的不寻常呈现

获取原文
       

摘要

Glucose-6-phosphate dehydrogenase (G6PD) deficiency can present a diagnostic dilemma owing to the varying degrees of disease severity and the wide range of precipitating factors. Here, we report a case of a 56-year-old man who presented with signs and symptoms of heart failure and, during the course of treatment, developed intravascular hemolysis. On investigation, he was found to be G6PD deficient. Following discontinuation of the fixed-dose combination of isosorbide dinitrate and hydralazine, the clinical condition of the patient improved, and there were no further episodes of hemolysis. The case highlights the need for a high degree of suspicion of G6PD deficiency in patients with unexplained signs and symptoms of intravascular hemolysis.
机译:葡萄糖-6-磷酸脱氢酶(G6PD)缺乏可能由于疾病严重程度和广泛的沉淀因子而呈现诊断困境。在这里,我们举报了一个56岁的男子患者患有心力衰竭的迹象和症状,并且在治疗过程中,产生血管内溶血。关于调查,他被发现是G6PD缺乏。停止在异山梨醇二硝酸盐和氢氮嗪的固定剂量组合后,患者的临床状况改善,并且没有进一步的溶血发作。这种情况强调了对具有无法解释的症状和血管内溶血症状的患者对G6PD缺乏的高度怀疑的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号